Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Probe Gold Inc
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
1,354.00
-10.73 (-0.79%)
Official Closing Price
Updated: 7:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Certified PEP MEX Expands Its Reach in Mexico With Two New Research Peptide Websites
Today 0:00 EST
Via
Press Release Distribution Service
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
November 06, 2026
From
Hims & Hers
Via
Business Wire
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
Growing Demand for Next-Generation Therapies Is Putting Peptide Innovation at the Center of Healthcare's Biggest Growth Markets
From
FN Media
Via
GlobeNewswire
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(OTCQX:RHHBY),(NYSE:NVO),(NASDAQ:VKTX),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Retatrutide Research Draws Attention in Costa Rica as Demand for Reliable Scientific Information Grows
November 03, 2026
Via
Press Release Distribution Service
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
Breakthroughs in obesity, diabetes, oncology, and targeted therapies are driving fresh interest in peptide-based medicines and the companies developing the next generation of treatments.
From
FN Media
Via
GlobeNewswire
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:NVO),(NYSE:HIMS),(NYSE:ENHA),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
October 06, 2026
From
Wall Street Investor
Via
GlobeNewswire
2026 Biotech Watchlist IBRX, PACB, IGC, VIVS Lead 7 Stocks in Focus
October 01, 2026
Via
AB Newswire
2026 Nanocap Stocks to Watch: IGC, KNRX, GYGY, ARAY Lead Watchlist Now See More Inside!
September 28, 2026
Via
AB Newswire
Topics
Artificial Intelligence
VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs
September 28, 2026
Via
AB Newswire
VivoSim Labs Inc. (NASDAQ: VIVS) Takes Aim at Pharma’s 92% Drug-Failure Problem
September 21, 2026
Via
AB Newswire
Topics
Animal Testing
VivoSim Labs (NASDAQ: VIVS): Predicting Drug Toxicity Before Human Clinical Trials
September 10, 2026
Via
AB Newswire
2025 R&D Spending And Intensity Benchmarks
September 09, 2026
Via
PRLog
Topics
Supply Chain
VivoSim Labs (NASDAQ: VIVS): 10,000 Compounds to 1 Drug with AI-Powered 3D Human Toxicology
August 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now
August 26, 2026
Via
AB Newswire
Topics
Artificial Intelligence
VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum
August 25, 2026
Via
AB Newswire
Topics
Animal Testing
Artificial Intelligence
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026
News Provided by USA News Group on behalf of MindWalk Holdings Corp.
From
USA News Group
Via
GlobeNewswire
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum
August 17, 2026
Via
AB Newswire
Topics
Animal Testing
Artificial Intelligence
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
News Provided by USA News Group on behalf of Conexeu Sciences Inc.
From
USA News Group
Via
GlobeNewswire
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
July 21, 2026
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
July 16, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
As Medicare’s New GLP-1 Coverage Begins, Ozari Health Publishes 2026 Guide Comparing Every Way to Get Semaglutide and Tirzepatide – From $50 Copays to $86 Cash-Pay Options
July 15, 2026
Via
AB Newswire
Dr. Danielle Carrera’s Beyond Better, Thrive Debuts as Amazon #1 New Release and Top 5 Bestseller
July 03, 2026
Via
Get News
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From
Biotech Insider
Via
GlobeNewswire
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy
June 22, 2026
Houston, Texas--(Newsfile Corp. - June 22, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) recently achieved what many biotechnology companies spend...
Via
Newsfile
GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation
June 03, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation
June 03, 2026
Recent Industry Activity Reinforces the Need for Manufacturing Resilience, Diversified Vaccine Supply, and Health Security Amid an Evolving Global Biothreat Landscape
Via
TheNewswire.com
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
May 21, 2026
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Government
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today